Skip to content
Screener

Jade Biosciences JBIO Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Climb Global Solutions, Inc. logo
Climb Global Solutions, Inc.CLMB
$1.54M-16.4%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$9.67M-26.7%
Vor Biopharma logo
Vor BiopharmaVOR
$2.83M-91.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$12.04M-13.5%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$983.41K+36.8%
Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
$447K-0.9%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.34B+454%
Enterprise value$1.28B+6,787%

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by Jade Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:27 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-212088
Line itemMarch 31,2026December 31,2025
Prepaid expenses and other current assets7,22212,658
Total current assets318,517348,816
Property and equipment, net157170
Operating lease right-of-use asset690726
Other assets6969
Total assets$319,433$349,781
Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit)
Current liabilities:

Item 1. Financial Statements.

FAQ

What is Jade Biosciences's operating lease ROU assets?
Jade Biosciences (JBIO) reported operating lease ROU assets of $690K in Q1 2026.
How has Jade Biosciences's operating lease ROU assets changed year-over-year?
Jade Biosciences's operating lease ROU assets increased by 336.7% year-over-year, from $158K to $690K.
What is the long-term trend for Jade Biosciences's operating lease ROU assets?
Over 4 years (2021 to 2025), Jade Biosciences's operating lease ROU assets has grown at a 7.6% compound annual growth rate (CAGR), from $542K to $726K.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Jade Biosciences's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude